ONETAXOTERE 80mg (Docetaxel Hydrate Vials) 80 mg

ONETAXOTERE 80mg contains docetaxel hydrate, a chemotherapy medication used for cancer treatment. This injectable vial formulation is stored below 25°C for stability. ONETAXOTERE 80mg is prescribed under medical supervision for specific oncology indications.

Strength

80 mg

Pack Size

Storage

Below 25°C

Manufacturer / TM Owner

Sanofi Aventis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Docetaxel hydrate, the active ingredient in ONETAXOTERE 80mg, is used to treat various cancers including breast, lung, and prostate cancers. It may also be prescribed for other oncological conditions as determined by healthcare providers. This chemotherapy agent works by interfering with cancer cell growth and division.

Side Effects

ONETAXOTERE 80mg may cause temporary side effects such as nausea, fatigue, or hair loss. Some patients experience changes in blood cell counts, which can increase infection risk. These effects vary by individual and treatment stage.

Precautions & Warnings

Handle ONETAXOTERE 80mg vials with care, avoiding skin contact due to potential irritation. Store below 25°C and protect from light. Use only as directed by a healthcare professional. Dispose of vials and related materials according to local regulations for cytotoxic drugs.

Avoid Interactions

Docetaxel may interact with medications that affect liver enzymes, such as CYP3A4 inhibitors or inducers. Alcohol and certain supplements could alter its effects. Always inform your healthcare provider about all medications and supplements being taken before starting treatment.

Frequently Asked Questions

ONETAXOTERE 80mg contains docetaxel hydrate, a chemotherapy drug used to treat specific cancers under medical supervision.

Store ONETAXOTERE 80mg vials below 25°C and protect from light until ready for use.

ONETAXOTERE 80mg is administered by healthcare professionals in a clinical setting due to its nature as a chemotherapy agent.

Common side effects may include nausea, fatigue, or changes in blood cell counts; discuss any concerns with your healthcare provider.

Yes, ONETAXOTERE 80mg should be handled with care to avoid skin contact and disposed of as cytotoxic waste.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.